CHEE CONLEY (Chief Commercial Officer) purchased 444.4% of their position (100K shares) of SYROS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $160.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/12/2024ACC: 0000950170-24-105994
Officer· Chief Commercial Officer
Since Sep 2021
+100K
Net shares
Net buyer
$160.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$1.51
Trade value
$75.26K
% of position
222.2%
9/10/2024
22.50K→72.50K
Common Stock
Direct
Shares
+50K
Price / share
$1.71
Trade value
$85.42K
% of position
69.0%
9/11/2024
72.50K→122.50K
Total
Net shares
+100K
Net value
$160.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2024 | P · Purchase | +50K | $1.51 | $75.26K | 222.2% | 22.50K | 72.50K |
| Common Stock Direct | 9/11/2024 | P · Purchase | +50K | $1.71 | $85.42K | 69.0% | 72.50K | 122.50K |
| Total | +100K | $160.68K | ||||||
Derivative Transactions0
No derivative transactions reported